αSTARTZ

WIPO WIPO 2022

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke αSTARTZ wurde als Bildmarke am 25.02.2022 bei der Weltorganisation für geistiges Eigentum angemeldet.

Logodesign (Wiener Klassifikation)

#Briefe, die eine besondere Form des Schreibens darstellen #Inschriften in griechischen Schriftzeichen #Briefe in schweren Buchstaben #28.07.00

Markendetails Letztes Update: 26. Mai 2023

Markenform Bildmarke
Aktenzeichen 1666551
Länder China Europäische Gemeinschaft Großbritannien Vereinigte Staaten von Amerika (USA)
Basismarke JP Nr. 2021-106646, 27. August 2021
Anmeldedatum 25. Februar 2022
Ablaufdatum 25. Februar 2032

Markeninhaber

3-4-10, Shinsuna,
Koto-ku
JP

Markenvertreter

Markstone IP Attorneys, Verty Nakano 202, 29-10, Honcho 3-chome, JP

Waren und Dienstleistungen

01 Industrial chemicals; chemical preparations for scientific purposes; diagnostic reagents for scientific or research use; chemicals for use in the manufacture of pharmaceuticals; chemicals for use in the manufacture of radiopharmaceuticals; radioactive elements for scientific purposes; isotopes for industrial purposes; peptide substrates for scientific purposes; peptide for use in the manufacture of pharmaceuticals; chelating agents for use in the manufacture of pharmaceuticals; polypeptides for scientific purposes; antibodies for scientific purposes, other than for medical or veterinary use; chelate compound; organic chelating agents; metal chelating agents
05 Pharmaceuticals; reagents for medical purposes; medical diagnostic reagents; radioactive substances for medical purposes; isotopes for medical purposes; radioisotope markers for therapeutic or diagnostic use; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; synthetic peptides for pharmaceutical purposes; pharmaceuticals consisting of antibodies; pharmaceuticals consisting of antibody fragments; pharmaceuticals consisting of antibody derivatives; antibodies for medical purposes
40 Custom manufacture of pharmaceuticals; custom manufacture of investigational new drug; custom manufacture of radiopharmaceuticals; custom synthesis of labeled compound; custom manufacture of peptides; custom manufacture of antibodies; custom manufacture of proteins; custom protein modification; custom antibody modification; custom extraction, refining or synthesis of pharmaceuticals and veterinary preparations; custom peptide synthesis services; custom refining, synthesis or manufacture of pharmaceuticals consisting of antibodies; custom refining, synthesis or manufacture of pharmaceuticals consisting of antibody fragments; custom refining, synthesis or manufacture of pharmaceuticals consisting of antibody derivatives; custom radioactive labeling of antibodies; custom radioactive labeling of antibody fragments; custom radioactive labeling of antibody derivatives; custom radioactive labeling of peptides
42 Research and development of medicines; testing, inspection or research services in the fields of pharmaceuticals; advisory, consultancy and providing information relating to testing, inspection or research services in the fields of pharmaceuticals; development of pharmaceuticals; advisory, consultancy and providing information relating to development of pharmaceuticals; conducting clinical trials for pharmaceuticals; advisory, consultancy and providing information relating to clinical trials for pharmaceuticals; research and development of radiopharmaceuticals; development of radiopharmaceuticals; advisory, consultancy and providing information relating to development of radiopharmaceuticals; research and development services relating to peptides; research and development services in the field of antibodies; research and development services relating to peptide labeling by radioactive substances; research and development services relating to antibody labeling by radioactive substances
45 Granting of licenses to others for the use of intellectual property; exploitation of industrial property rights [legal services]
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
15. Februar 2023 2023/7 Gaz US Ablehnung
09. November 2022 2022/45 Gaz CN Ablehnung
08. November 2022 2022/45 Gaz EM Ablehnung
08. September 2022 2022/38 Gaz GB Ablehnung
25. Februar 2022 2022/22 Gaz JP Eintragung

ID: 141666551